JUVARIS BIOTHERAPEUTICS INC has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are O'HAGAN DEREK, NEWBIOMED PIKA PTE LTD and NORDIC VACCINE TECHNOLOGY AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds | |
#5 | Climate change adaptation technologies | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Fairman Jeffery | 11 |
#2 | Dow Steven W | 7 |
#3 | Yu Cheng-Sein | 6 |
#4 | Bussey Lee B | 6 |
#5 | Vaughn Marla | 3 |
#6 | Jeffery Fairman | 2 |
#7 | Callejo Bernadette | 1 |
#8 | Maria Vaughn | 1 |
#9 | Cohen Gary H | 1 |
#10 | Monath Tom | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011106607A2 | Subunit vaccines for herpes viruses and methods of use | |
US2010086584A1 | VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES | |
US2010280258A1 | Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds | |
EP2257306A1 | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) | |
WO2008057696A2 | Compositions of pattern recognition receptor-ligand: lipid complexes and methods of use thereof | |
CN101304759A | Vaccines using pattern recognition receptor-ligand:lipid complexes |